Abbott and MSD Pharmaceuticals announced a partnership to distribute oral anti-diabetic medicines, specifically sitagliptin, ...

The drug patents expired in India in July 2022, which has triggered a wave of generic launches and steep price corrections across the market.

Explore the critical links between angina and heart disease in women in India, highlighting expert insights, health awareness ...

The Supreme Court on Wednesday restarted plans to temporarily store nuclear waste at sites in rural Texas and New Mexico, ...

India is seeing a rise in Covid-19 cases, with new variants spreading quickly. Pregnant women, especially those with ...

Ypsomed and CamDiab announced that they continued the launch of the iOS version of their automated insulin delivery app in ...

Abbott partners with MSD to distribute leading diabetes medications in India, enhancing patient access and care.

Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care ...

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott Labs received a confidence boost from Oppenheimer, which stuck to its $140 price target and Outperform rating. The ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes for patients who have type 2 diabetes.